Previous Article | Next Article 
Infection and Immunity, January 1999, p. 237-243, Vol. 67, No. 1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Compensation for Decreased Expression of B7
Molecules on Leishmania infantum-Infected Canine Macrophages
Results in Restoration of Parasite-Specific T-Cell Proliferation and
Gamma Interferon Production
Elena
Pinelli,1,*
Victor P. M. G.
Rutten,1
Martijn
Bruysters,1
Peter F.
Moore,2 and
E. Joost
Ruitenberg1,3
Department of Immunology, Faculty of
Veterinary Medicine, 3584 CL Utrecht,1 and
Central Laboratory of The Netherlands Red Cross Blood
Transfusion Service, Amsterdam,3 The
Netherlands, and
Department of Veterinary Pathology, School of
Veterinary Medicine, University of California, Davis, California
95616-87392
Received 26 May 1998/Returned for modification 3 August
1998/Accepted 5 October 1998
 |
ABSTRACT |
Infection of humans and dogs by Leishmania infantum may
result in visceral leishmaniasis, which is characterized by impaired T-cell-mediated immune responses to parasite antigens. Dogs are natural
hosts of Leishmania parasites and play an important role in
the transmission of the parasites to humans. In an effort to characterize the immune response in dogs infected with this
intracellular pathogen, we examined how infection with L. infantum affects canine macrophages and the consequences for
T-cell activation in vitro. We showed that the proliferation of T-cell
lines to cognate antigen decreases to background levels when infected
autologous monocyte-derived macrophages are used as antigen-presenting
cells (APC). The observed reduction of antigen-specific T-cell
proliferation was shown to be dependent on the parasite load and to
require cell-to-cell interaction of T cells with the infected APC. In
addition, we observed a decreased expression of costimulatory B7
molecules on infected monocyte-derived macrophages. The expression of
other surface molecules involved in T-cell activation, such as major histocompatibility complex class I and class II, on these cells did not
change upon infection, whereas the expression of intracellular adhesion
molecule 1 was marginally increased. Compensation for the decreased
expression of B7 molecules by the addition of B7-transfected cells
resulted in the restoration of cell proliferation and gamma interferon
(IFN-
) production by a Leishmania-specific T-cell line.
These results showed that for the activation of parasite-specific canine T cells producing IFN-
, which are most likely involved in
protective immunity, sufficient expression of B7 molecules on infected
macrophages is required. Provision of costimulatory molecules may be an
approach for immunotherapy of leishmaniaisis as well as for vaccine development.
 |
INTRODUCTION |
The intracellular protozoan parasite
Leishmania infantum, transmitted by the female sandfly of
the genus Phlebotomus, causes visceral leishmaniasis in both
humans and dogs in Mediterranean countries (1). Parasites
invade and multiply within macrophages (M
) of the viscera, causing a
fatal disease if untreated because of the failure of the host to
generate a protective immune response.
In progressive disease, cellular immune responses are impaired, as
indicated by studies showing that peripheral blood lymphocytes (PBL)
from affected humans and dogs fail to respond to parasite antigens both
in vitro and in vivo. Protective immunity has generally been associated
with a distinct cellular immune response, manifested by a strong
proliferative response of PBL to leishmanial antigens (4, 5, 28,
35) and the production of cytokines, such as gamma interferon
(IFN-
) and tumor necrosis factor, which are required for M
activation and killing of intracellular parasites (17, 18, 25,
29).
M
play an important role in the immune response against
Leishmania parasites, since they are the host cells for the
parasites; they are potential antigen-presenting cells (APC) and,
depending on their capacity to respond to T-cell-derived cytokines
during the course of the disease, can kill intracellular pathogens.
Initial studies have suggested impaired antigen presentation by
infected M
(13). For T-cell activation by APC, engagement
of the T-cell receptor (TCR) with a peptide-major histocompatibility
complex (MHC) complex and interaction between costimulatory molecules are required (3). Engagement of the TCR in the absence of
costimulation can lead to the induction of T-cell unresponsiveness
(15). Whether L. infantum interferes with the
activation of protective T cells by modulation of either of the signals
required for T-cell activation in dogs remains to be studied.
Here we report on the decreased proliferation of T-cell lines to
cognate antigen when canine monocyte-derived M
(MDM) infected with
L. infantum were used as APC. Analysis of the expression of
various surface molecules indicated a decreased expression of
costimulatory B7 molecules on infected APC. The decreased T-cell proliferation and IFN-
production by a
Leishmania-specific T-cell line could be overcome by
compensating for the decreased expression of B7 molecules on infected
APC by adding B7.1-transfected fibroblasts. The expression of other
surface molecules involved in T-cell activation, such as MHC class I
and class II, on these APC did not change upon infection, whereas the
expression of intracellular adhesion molecule 1 (ICAM-1) was marginally
increased. These data demonstrate an important role for B7 molecules in
parasite-specific T-cell proliferation and IFN-
production and
suggest down-regulation of B7 expression on infected APC as a way for
this intracellular pathogen to evade the immune response of the host.
The implications of these parasite-induced changes on the immune
response of the host to L. infantum are discussed.
 |
MATERIALS AND METHODS |
Parasites and dogs.
L. infantum (MCAN/ES/88/1SS441
DOBA) parasites were maintained as promastigotes at 25°C in RPMI 1640 medium (Gibco, Pasley, Renfrewshire, United Kingdom) supplemented with
10% fetal calf serum (Sera Lab, Crawley Down, Sussex, United Kingdom),
2 mM L-glutamine (Gibco), 100 IU of penicillin (Gibco) per
ml, and 100 µg of streptomycin (Gibco) per ml. Parasites at the
stationary phase of growth were used for infection of MDM. The dogs
used in this study were healthy animals housed at the animal facility
of the Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Generation of T-cell lines.
An L. infantum-specific T-cell line was generated from the peripheral
blood of a beagle dog (no. 9157) that was immunized with
Leishmania soluble antigen (LSA) by a procedure described previously (27). For these experiments, at 14 days after
initial stimulation, the T-cell line (106 cells/ml) was
restimulated by the addition of irradiated (6,000 rads) autologous MDM
(105 cells/ml) and LSA (10 µg/ml). After 72 h, the
culture supernatant was harvested and IFN-
activity was measured by
a bioassay (29). Dohyvac, a combination canine vaccine
(Duphar B. V., Weesp, The Netherlands) against distemper,
hepatitis, and parainfluenza, routinely administered to the dogs, was
also used to generate T-cell lines from dog 9158. For restimulation,
Dohyvac was inactivated by UV irradiation for 20 min and subsequently
boiled for 10 min. Dohyvac soluble antigen (35 µg/ml) was added to
Dohyvac-specific T cells together with irradiated MDM as described above.
MDM.
Canine MDM were prepared from peripheral blood of
beagle dogs as described in detail elsewhere (29). Briefly,
peripheral blood mononuclear cells were plated in 9.5-cm2
wells of six-well plates (Costar, Cambridge, Mass.) at 6 × 106 cells/well for 2 h at 37°C in 5%
CO2. Nonadherent cells were removed, and the monolayer of
adherent monocytes was washed gently with prewarmed culture medium
(RPMI 1640 medium supplemented with 10% FCS, 2 mM
L-glutamine, 100 IU of penicillin per ml, and 100 µg of
streptomycin per ml). MDM were obtained after differentiation of
monocytes by maintaining the adherent cells for an additional 5 days at
37°C in 5% CO2.
Flow cytometric analysis.
The expression of various surface
molecules on MDM was analyzed with monoclonal antibodies directed
against canine ICAM-1 (CL18.1D8) (26) and human MHC class I
(B1.1.G.6) and class II (7.5.10.1), shown to cross-react with canine
MHC molecules (8); the antibodies were kindly provided by F. Koning, Academic Hospital, Leiden, The Netherlands.
Determination of the expression of various T-cell markers was carried
out with monoclonal antibodies directed against canine Thy.1 (8.358),
CD4 (12.125), and CD8 (1.140), (11), kind gifts from D. Gebhard, College of Veterinary Medicine, North Carolina State
University. Monoclonal antibodies against canine TCR
/
(CA15.8G7)
and TCR
/
(CA20.6A3) (22, 23) were also included in
this study. Incubation of 105 cells with the appropriate
dilutions of the antibodies was performed for 20 min at 4°C. Cells
were washed with phosphate-buffered saline containing 5% normal dog
serum and incubated for a further 20 min at 4°C with fluorescein
isothiocyanate-conjugated antibody specific for mouse immunoglobulin G
(IgG) (Becton Dickinson, Mountain View, Calif.). The soluble CTLA4-Ig
fusion protein used to measure the expression of costimulatory B7
molecules (20) was generously provided by P. Linsley
(Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle,
Wash.). For experiments with CTLA4-Ig, human IgG was used as a control
antibody and fluorescein isothiocyanate-conjugated antibody specific
for human IgG (Becton Dickinson) was used as the detecting antibody.
The relative fluorescence intensity was measured on a FACScan apparatus
(Becton Dickinson).
Infection of MDM and proliferation of T-cell lines.
Monolayers of MDM were infected with promastigotes of L. infantum at a parasite-to-MDM ratio of 50:1 (unless indicated
otherwise) for 1 h at 37°C in 5% CO2. Residual
parasites were removed by gentle washing with prewarmed medium.
Infected MDM were incubated for a further 24 h, gently washed with
prewarmed medium, and then collected by incubation with ice-cold
phosphate-buffered saline-EDTA for 10 min. The final number of cells
was controlled for every experiment after infection and washes. The
number of intracellular parasites per MDM was determined by counting
intracellular parasites in at least 100 infected cells by microscopic
examination of Giemsa-stained preparations.
To assay proliferative responses, T-cell lines (5 × 104/well) and irradiated (6,000 rads) autologous uninfected
or infected MDM (5 × 103 cells/well) were incubated
in flat-bottom 96-well microtiter plates (Costar) in the presence of
either concanavalin A (ConA; Sigma, St. Louis, Mo.) (2 µg/ml), LSA
(10 µg/ml), or Dohyvac (35 µg/ml) or in the absence of antigen in a
total volume of 200 µl of RPMI 1640 medium supplemented with 10%
FCS, 2 mM L-glutamine, 100 IU of penicillin per ml, 100 µg of streptomycin per ml, and 10
5 M 2-mercaptoethanol
(Fluka AG, Buchs, Switzerland) (28). Cells were cultured for
4 days at 37°C in 5% CO2 and pulsed with
[3H]thymidine during the last 18 h. Cells were
harvested on glass-fiber filters, and [3H]thymidine
incorporation was determined by liquid scintillation counting. All
tests were performed in triplicate. Proliferative responses were
expressed as mean counts per minute ± standard deviations (SD).
Human B7.1-transfected 3T6-Fc

RII/B7 (3TB7) and untransfected
3T6-Fc

RII (3TFII) cell lines and a monoclonal antibody directed
against human B7.1 molecules (
7) (kindly provided by Mark de
Boer, Pan Genetics, Amsterdam, The Netherlands) were also used
in this
study. Irradiated (8,000 rads) 3TB7 or 3TFII fibroblasts
(1,000 cells/well) were added to cultures of
L. infantum-specific
T
cells and autologous uninfected or infected MDM as described
above.
Transwell cultures.
To determine whether infected MDM
produce soluble factors that may modulate antigen-specific T-cell
proliferation, coincubation of an L. infantum-specific
T-cell line in close proximity with infected MDM but without direct
cell-to-cell contact was achieved by use of a dual-chamber Transwell
culture system (Costar). In this system, 3 × 105
Leishmania-specific T cells were cultured with 3 × 104 irradiated (6,000 rads) uninfected MDM and 10 µg of
LSA per ml or medium only in 600 µl in the lower compartment.
L. infantum-infected or uninfected MDM (3 × 104 in 100 µl) were added to the upper compartment. As a
control, parasite-specific T cells were incubated with infected MDM in the lower compartment and medium only in the upper compartment. Cells
were incubated at 37°C in 5% CO2 for 4 days and pulsed
with [3H]thymidine during the last 18 h. Each
experiment was performed in triplicate. Cells from the lower well were
reseeded in a 96-well plate (Costar) and harvested on glass-fiber
filters as described above.
Statistical analysis.
The data were expressed as mean counts
per minute ± SD. The statistical significance (P < 0.05) of the data was evaluated by Student's t test of
paired samples.
 |
RESULTS |
Reduced proliferation of and IFN-
production by CD4+
T-cell lines upon stimulation with L. infantum-infected
MDM.
Antigen-specific T-cell lines were generated from immunized
animals and restimulated in vitro with autologous MDM as APC and cognate antigen. Proliferation of the Dohyvac-specific T-cell line to
cognate antigen was significantly decreased (P < 0.05) relative to background levels when L. infantum-infected MDM
were used as APC relative to uninfected MDM (Fig.
1a). In contrast, polyclonal stimulation
of this T-cell line after incubation with either uninfected or L. infantum-infected MDM and the mitogen ConA was not significantly
different (Fig. 1b). In addition, we observed that restimulation of a
Leishmania-specific T-cell line with LSA and infected MDM
resulted in significantly (P < 0.05) decreased
proliferation (Fig. 1c) and production of IFN-
(Fig. 1d) relative to
background levels and relative to restimulation of this T-cell line
with uninfected MDM. No significant difference in the proliferation of
this T-cell line in the presence of either infected or uninfected APC
and ConA was observed (data not shown). Analysis by flow cytometry of
the T-cell lines used in this study indicated that both Dohyvac- and
Leishmania-specific T-cell lines were Thy.1+,
CD4+, and TCR
/
+ cells.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 1.
T-cell proliferation against cognate antigen is reduced
when L. infantum-infected MDM are used as APC. Uninfected
MDM or L. infantum-infected MDM (MDM-L) were used as APC.
Cells were incubated in medium only ( ) or in the presence of cognate
antigen ( ). (a and b) A Dohyvac-specific T-cell line was stimulated
with Dohyvac (a) or ConA (b). (c and d) A
Leishmania-specific T-cell line was stimulated with LSA (c),
and after 72 h supernatants were collected for determination of
IFN- activity (d). Results are expressed as mean ± SD. Data
are representative of three independent experiments. SU, standard
units.
|
|
Reduced proliferation of an L. infantum-specific T-cell
line upon stimulation by infected MDM is dependent on the parasite
load.
To determine whether the number of intracellular parasites
per macrophage influences the observed reduction of T-cell
proliferative responses, MDM were infected at different parasite-to-MDM
ratios and used as APC. When MDM were infected at a 50:1 ratio,
reduction of antigen-specific T-cell proliferation to background levels was observed (Fig. 2). Infection of MDM
at a 10:1 ratio led to a significant reduction of the T-cell
proliferative response to LSA which, however, remained above background
levels. In contrast, MDM infected at a 2:1 ratio and used as APC
resulted in no reduction of the Leishmania-specific T-cell
proliferative response to LSA. Infection carried out at a
parasite-to-MDM ratio of 50:1 resulted in 96% ± 3% infected cells
with 15 ± 2.9 intracellular parasites per infected cell. This
number of parasites per infected cell can be found in dogs with
visceral leishmaniasis. At a 10:1 parasite-to-MDM infection ratio, 70% ± 7% of the cells were infected, with 5 ± 2.5 intracellular
parasites per infected MDM. Infection at a 2:1 ratio resulted in 30% ± 5% infected cells with 1.5 ± 1.0 intracellular parasites per
infected MDM.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of the parasite load of MDM on the proliferation
of a Leishmania-specific T-cell line against LSA. Autologous
uninfected MDM ( ) or MDM infected at a 2:1 ( ), 10:1 ( ), or
50:1 ( ) ratio were used as APC to stimulate a
Leishmania-specific T-cell line. Background proliferation of
T-cell lines incubated with APC and medium only ranged from 15,000 to
24,000 cpm. Results are expressed as mean ± SD counts per minute.
*, significant difference from Leishmania-specific T cells
stimulated with uninfected cells. Data are representative of three
independent experiments. MDM-L, L. infantum-infected MDM.
|
|
Decreased T-cell proliferation upon stimulation by
Leishmania-infected MDM requires cell-to-cell
interactions.
To determine whether infected MDM require
cell-to-cell interactions with T cells for decreased proliferative
responses to occur or whether these responses are mediated by soluble
factors, a Transwell system was used. As shown in Table
1, no significant differences in the
proliferative response of the Leishmania-specific T-cell
line to LSA were observed when infected MDM were separated from
responder cells by the semipermeable membrane relative to uninfected
MDM and medium only. L. infantum-infected MDM were also
cultured with the T-cell line in the lower compartment and medium only
in the upper compartment; these conditions resulted in a reduction of
the proliferative response to LSA to background levels. Thus, decreased
T-cell proliferation in vitro does not appear to be mediated by soluble
factors but instead seems to require cell-to-cell contact. An
additional control experiment was performed by mixing MDM and L. infantum-infected MDM in the presence of LSA and
Leishmania-specific T cells. Under these conditions, T-cell
proliferation was restored, compared to the results obtained with
L. infantum-infected MDM alone (data not shown). These
results indicate that there is no contact-dependent suppression but
rather a failure of infected MDM to stimulate antigen-specific T-cell proliferation.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Effect of coculturing with uninfected versus infected MDM
on the proliferation of a Leishmania-specific T-cell line in
a Transwell systema
|
|
Infection with L. infantum leads to changes in the
expression of surface molecules on canine M
.
The observed
decreased proliferative responses of the T-cell lines to parasite
antigen may have resulted from altered expression on infected APC of
surface molecules which are required for T-cell activation. As the TCR
recognizes antigen as peptide fragments in the context of MHC
molecules, we analyzed the expression of MHC class II and class I
molecules on canine MDM before and after infection with L. infantum by flow cytometry. For this purpose, MDM were infected at
a 50:1 infection ratio, which resulted in 98% ± 5% infected cells
with 12 ± 3 parasites per infected MDM. Canine MDM that have been
cultured for 5 days in vitro express both MHC class II and MHC class I
molecules. At 24 h after infection, the expression of both MHC
class II and MHC class I on infected MDM did not change compared to
that on uninfected cells (Fig. 3a and b).
Similar results were found 48 h after infection (data not shown).
The expression of other molecules involved in interactions between APC
and T cells, such as ICAM-1, was found to be marginally increased upon
infection of MDM with L. infantum (Fig. 3c). In contrast,
the expression of costimulatory B7 molecules on infected MDM was
strongly decreased compared to that on uninfected cells (Fig.
4).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
Expression of MHC class I and class II and ICAM-1 on
canine MDM. Monoclonal antibodies B1.1.G6 (a) directed against MHC
class I, 7.5.10.1 (b) directed against MHC class II, and CL18.1D8 (c)
directed against ICAM-1 were used to analyze the expression of these
molecules on uninfected MDM (dotted line) and L. infantum-infected MDM (solid line) 24 h after infection.
Scores of mean fluorescence intensity (MFI) are given in parentheses.
MDM were infected at a 50:1 parasite-to-MDM ratio. Incubation of cells
with an irrelevant mouse isotype control antibody resulted in an MFI of
13.70 (vertical broken line). The data shown are representative of four
independent experiments. Fl 1, fluorescence.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
Expression of B7 molecules on canine MDM. The expression
of B7 molecules on uninfected MDM (dotted line) and L. infantum-infected MDM (solid line) was analyzed with fusion
protein CTLA4-Ig. Scores of mean fluorescence intensity (MFI) are given
in parentheses. As a control, human Ig was used and resulted in an MFI
of 65.52 (vertical broken line). MDM were infected at a 50:1
parasite-to-MDM ratio. The data shown are representative of four
independent experiments. Fl 1, fluorescence.
|
|
Compensation for decreased B7 expression on infected MDM results in
restoration of Leishmania-specific T-cell proliferation and
IFN-
production.
The importance of costimulatory B7 molecules
for antigen-specific proliferation of canine T cells is shown in Fig.
5. The addition of CTLA4-Ig, which
interacts with canine B7 molecules, in the presence of
Leishmania-specific T cells, MDM as APC, and LSA resulted in
decreased proliferative responses compared to those in cells incubated
in the presence of human Ig, used as a control antibody.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 5.
T-cell proliferation against cognate antigen is
dependent on interactions with B7 molecules. A
Leishmania-specific T-cell line was restimulated with MDM as
APC in the presence of LSA ( ) or medium only ( ). Cells were
incubated in the presence of 10 µg of human IgG per ml used as a
control antibody (hIg) or CTLA4-Ig. The data shown are representative
of two independent experiments and are expressed as mean ± SD.
|
|
To investigate the relevance of the observed down-regulation of B7
expression on
L. infantum-infected MDM for parasite-specific
T-cell proliferation, B7-transfected fibroblasts were added to
the
cultures. Fig.
6a shows that the addition
of transfected 3TB7
cells to T cells and
L. infantum-infected MDM resulted in the
restoration of
parasite-specific T-cell proliferation compared
to the proliferation of
T cells cultured with infected MDM in
the absence of 3TB7 or in the
presence of untransfected 3TFII
cells. T-cell proliferation was
restored when cells were incubated
with infected MDM and 3TB7 cells
both in the presence of LSA and
in medium only. The observed effect of
transfected 3TB7 cells
on
Leishmania-specific T-cell
proliferation was blocked when 3TB7
cells were incubated in the
presence of 5 µg of a monoclonal antibody
directed against human B7.1
molecules per ml compared to an isotype
control antibody (Fig.
6b).
From previous studies, it was shown
that this monoclonal antibody does
not cross-react with canine
B7 molecules. The IFN-

concentration in
supernatants derived
from T cells stimulated with infected MDM, LSA,
and 3TB7 cells
was 1,120 ± 226 standard units/ml; in contrast,
this cytokine
was undetectable in supernatants derived from T cells
stimulated
with infected MDM and LSA in the absence of 3TB7 cells or
the
presence of 3TFII cells.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 6.
Restoration of antigen-specific T-cell proliferation in
the presence of infected APC is dependent on interactions with B7
molecules. (a) B7.1-transfected 3TB7 cells or untransfected 3TFII cells
(1,000 cells/well) were added to a Leishmania-specific
T-cell line incubated with L. infantum-infected MDM (MDM-L)
in the presence of LSA ( ) or medium only ( ). (b) A
Leishmania-specific T-cell line was restimulated with LSA,
infected MDM, and 3TFII cells ( ) or 3TB7 cells without a monoclonal
antibody ( ), with a monoclonal antibody against human B7.1 molecules
( ), or with a control monoclonal antibody ( ). Background
proliferation of T-cell lines incubated with infected MDM and medium
only ranged from 13,055 to 16,062 cpm. Results are expressed as
mean ± SD.
|
|
 |
DISCUSSION |
We previously showed that PBL from symptomatic dogs infected with
L. infantum fail to respond both in vitro and in vivo to parasite antigens (28). T-cell unresponsiveness to parasite antigens was also reported for human visceral leishmaniasis (14, 35). However, following successful chemotherapy, T-cell
responsiveness was found to be fully restored (5, 12). The
cellular basis for T-cell unresponsiveness is still not fully
understood. Since Leishmania parasites are obligate
intracellular pathogens that reside within M
, several studies of the
effect of infection on M
functions have been carried out. Infection
of murine M
with L. donovani was shown to result in
decreased expression of MHC class I and II molecules and interleukin 1 (IL-1) secretion (32, 33). In contrast, our studies showed
that infection of canine MDM with L. infantum does not
result in any significant change in the surface expression of MHC class
I and II molecules. Others have also observed that decreased
antigen-presenting capacity of L. major-infected murine M
could not be attributed to an unavailability of MHC class II molecules
or impaired processing of antigen by the infected cells
(10). These authors suggested that the presence of the
parasites could interfere with the intracellular loading of MHC class
II molecules with antigenic peptides.
Another possible mechanism by which decreased proliferation of T cells
may occur is through the induction of soluble factors produced by
infected M
. This mechanism has been shown for M
from BALB/c mice
infected with L. donovani, for which the synthesis of
prostaglandin E2, a known down-regulator of class II
expression (37), was enhanced compared to that for
uninfected M
. Cytokines such as transforming growth factor
,
which was found to be associated with down-regulation of the activation
of Th1-type cells involved in protective responses in murine cutaneous
leishmaniasis, may be produced by M
upon infection (2).
The alteration in the cytokine profile may vary depending on the origin
of the M
and the species of Leishmania. Studies of murine
leishmaniasis have shown that infecting M
with L. major
results in very little, if any, production of cytokines such as IL-6,
transforming growth factor
, IL-12, and IL-10 (6, 34).
Using a Transwell system, we observed that cell-to-cell interactions
are required for the decreased T-cell proliferation observed.
Several studies have shown that Leishmania-infected murine
M
activate antigen-specific T cells less efficiently than uninfected cells (10, 21, 30). However, Chakkalath and Titus
(6) showed that only Th1-type cells are less efficiently
activated by L. major-infected M
, whereas Th2-type T-cell
activation is enhanced in response to stimulation with infected M
and cognate antigen. In our study, both the proliferative response of
and the amount of IFN-
produced by the
Leishmania-specific T-cell line were decreased after
restimulation with LSA and L. infantum-infected M
compared to uninfected cells. Whether Th2-type cells are activated by
infected M
in dogs is a question that could be addressed when tools
to measure cytokines such as IL-4 become available. We have also shown
that protective immunity is associated with a Th1 type of response in
dogs, as indicated by parasite-specific proliferation of and IFN-
production by PBL from L. infantum-infected asymptomatic dogs (29). Characterization of the mechanism by which the
reactivity of Th1-type cells is down-regulated is of crucial importance
for vaccine development or immunotherapy of leishmaniasis.
T-cell proliferation and induction of effector functions require the
recognition of peptide-MHC complexes by the TCR and interactions between costimulatory molecules. The interaction between the B7 family
of membrane molecules on APC and their receptors on T cells appears to
be an important costimulatory signal (9, 19). We observed
that B7 molecules play an important role in antigen-specific proliferation of canine T cells. An additional observation was the
reduction of the expression of B7 molecules on infected canine MDM
compared to uninfected cells. If this reduction were the cause of the
observed reduction of T-cell proliferation when infected MDM were used
as APC, proliferative responses could be restored by the addition of
anti-CD28 antibodies. As no antibodies to canine CD28 molecules or
cross-reactive antibodies are available, we tried to compensate for the
decreased B7 expression on canine MDM by adding B7.1-transfected cells,
which would provide in trans costimulation to T cells. This
approach resulted in restoration of the proliferation of and IFN-
production by a Leishmania-specific T-cell line, indicating
an important role of these molecules in the activation of the Th1 type
of parasite-specific T cells. In addition, we observed the restoration
of T-cell proliferation after incubation with 3TB7 cells not only in
the presence of LSA but also in medium only, suggesting that infected
MDM can process and present antigen derived from intracellular
parasites but fail to do so because of decreased B7 expression.
Deficient expression of B7.1 molecules on L. donovani-infected M
derived from BALB/c mice (16,
36) but not on infected C57BL/6 M
has been reported
(36), suggesting that selective down-regulation of
costimulatory molecules by Leishmania parasites may
influence the outcome of the disease. Recently, Murphy et al.
(24) reported that selective B7.2 blockade enhances T-cell responsiveness to L. donovani and was found to be associated
with clearance of the parasites from the livers of infected mice.
Selective manipulation of the expression of costimulatory molecules may be of importance for vaccine development. Probst et al. (31) have suggested LeIF, a Leishmania protein, as a Th1-type
adjuvant due to its immunomodulatory characteristics, including
up-regulation of the expression of B7.1 molecules.
In addition to the down-regulation of B7 molecules on infected MDM, we
observed a marginal increase in the expression of ICAM-1. This finding
has been described by others for the murine model of visceral
leishmaniasis as well (36). These molecules not only have
been implicated in regulating interactions between cells but also can
directly contribute to lymphocyte activation (38, 39) and
may play a role in the outcome of infection.
Our results show that decreased T-cell proliferation against cognate
antigen is dependent on the parasite load. Furthermore, we observed
that cells with infection ratios of 50:1 and 10:1 showed decreased
expression of B7 molecules, whereas cells infected at 2:1 did not (data
not shown). These results indicate that the parasite load plays an
important role in the modulation of the immune response.
In conclusion, our results indicate that costimulatory B7 molecules are
required for proliferation of and IFN-
production by canine
Leishmania-specific T cells. Down-regulation of the expression of costimulatory molecules on M
may serve as an
additional mechanism used by these parasites to evade the protective
immune responses of the host and may contribute to the impaired
T-cell-mediated protective immune responses observed for patients with
progressive visceral leishmaniasis. Compensation for decreased B7
expression on infected M
may be an approach for the immunotherapy of leishmaniasis.
 |
ACKNOWLEDGMENTS |
We are grateful to Rene van Lier and Claire Boog for critically
reading the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Immunology, Institute of Infectious Diseases and Immunology, Faculty of
Veterinary Medicine, University of Utrecht, P.O. Box 80.165, 3508 TD
Utrecht, The Netherlands. Phone: 31-30-2534608. Fax: 31-30-2533555. E-mail: e.pinelli{at}vet.uu.nl.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Ashford, R. W., and S. Bettini.
1987.
Ecology and epidemiology: Old World, p. 365-424.
In
W. Peters, and R. Killick-Kendrick (ed.), Leishmaniasis in biology and medicine. Academic Press, Inc., New York, N.Y.
|
| 2.
|
Barral, N. M.,
A. Barral,
C. E. Brownell,
Y. A. Skeiky,
L. R. Ellingsworth,
D. R. Twardzik, and S. G. Reed.
1992.
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.
Science
257:545-548[Abstract/Free Full Text].
|
| 3.
|
Bretscher, P.
1992.
The two signal model of lymphocyte activation twenty-one years later.
Immunol. Today
13:74-76[Medline].
|
| 4.
|
Cabral, M.,
J. O'Grady, and J. Alexander.
1992.
Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs.
Parasite Immunol.
14:531-539[Medline].
|
| 5.
|
Carvalho, E. M.,
R. S. Teixeira, and W. D. Johnson, Jr.
1981.
Cell-mediated immunity in American visceral leishmaniasis.
Infect. Immun.
48:409-414.
|
| 6.
|
Chakkalath, H. R., and R. G. Titus.
1994.
Leishmania major-parasitized macrophages augment Th2-type T cell activation.
J. Immunol.
153:4378-4387[Abstract].
|
| 7.
|
de Boer, M.,
P. Parren,
J. Dove,
F. Ossendorp,
G. van der Horst, and J. Reeder.
1992.
Functional characterization of a novel anti-B7 monoclonal antibody.
Eur. J. Immunol.
22:3071-3075[Medline].
|
| 8.
|
Doveren, R. F. C.,
W. A. Buurman,
B. Schutte,
G. Groenewegen, and C. J. Van der Linden.
1985.
Class II antigens on canine T lymphocytes.
Tissue Antigens
25:255-265[Medline].
|
| 9.
|
Freeman, G. J.,
G. S. Gray,
C. D. Gimmi,
D. B. Lombard,
L. Zhou,
M. White,
J. D. Fingeroth,
J. G. Gribben, and L. M. Nadler.
1991.
Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.
J. Exp. Med.
174:625-631[Abstract/Free Full Text].
|
| 10.
|
Fruth, U.,
N. Solioz, and J. A. Louis.
1993.
Leishmania major interferes with antigen presentation by infected macrophages.
J. Immunol.
150:1857-1864[Abstract].
|
| 11.
|
Gebhard, D. H., and P. B. Carter.
1992.
Identification of canine T-lymphocyte subsets with monoclonal antibodies.
Vet. Immunol. Immunopathol.
33:187-199[Medline].
|
| 12.
|
Haldar, J. P.,
S. Ghose,
K. C. Saha, and A. C. Ghose.
1983.
Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.
Infect. Immun.
42:702-707[Abstract/Free Full Text].
|
| 13.
|
Handman, E.,
R. Ceredig, and G. F. Mitchell.
1979.
Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.
Aust. J. Exp. Biol. Med. Sci.
57:9-30[Medline].
|
| 14.
|
Ho, M.,
D. K. Koech,
D. M. Iha, and A. D. M. Bryceson.
1983.
Immunosuppression in Kenyan visceral leishmaniasis.
Clin. Exp. Immunol.
51:207-214[Medline].
|
| 15.
|
Jenkins, M. K.
1992.
Models of lymphocyte activation.
Immunol. Today
13:69-73[Medline].
|
| 16.
|
Kaye, P. M.,
N. J. Rogers,
A. J. Curry, and J. C. Scott.
1994.
Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages.
Eur. J. Immunol.
24:2850-2854[Medline].
|
| 17.
|
Kemp, M.,
J. A. L. Kurtzhals,
K. Bendtzen,
L. K. Poulsen,
M. B. Hansen,
D. K. Koech,
A. Kharazmi, and T. G. Theander.
1993.
Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
Infect. Immun.
61:1069-1073[Abstract/Free Full Text].
|
| 18.
|
Liew, F. Y., and C. A. O'Donell.
1993.
Immunology of leishmaniasis.
Adv. Parasitol.
32:161-259[Medline].
|
| 19.
|
Linsley, P. S.,
W. Brady,
L. Grosmaire,
A. Aruffo,
N. K. Damle, and J. A. Ledbetter.
1991.
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.
J. Exp. Med.
173:721-730[Abstract/Free Full Text].
|
| 20.
|
Linsley, P. S.,
W. Brady,
M. Urnes,
L. S. Grosmaire,
N. K. Damle, and J. A. Ledbetter.
1991.
CTLA-4 is a second receptor for the B cell activation antigen B7.
J. Exp. Med.
174:561-569[Abstract/Free Full Text].
|
| 21.
|
Lytton, S. D.,
E. Mozes, and C. Jaffe.
1993.
Effect of macrophage infection by Leishmania on the proliferation of an antigen-specific T cell line, TPB1, to non-parasite antigen.
Parasite Immunol.
15:489-492[Medline].
|
| 22.
|
Moore, P. F., and P. V. Rossitto.
1993.
Development of monoclonal antibodies to the canine T cell receptor complex (TCR/CD3) and their utilization in the diagnosis of T cell neoplasia.
Vet. Pathol.
30:457.
|
| 23.
|
Moore, P. F.,
P. V. Rossitto, and T. Olivry.
1994.
Development of monoclonal antibodies to canine T cell receptor-1 (TCR- ) and their utilization in the diagnosis of epidermotropic cutaneous T cell lymphoma.
Vet. Pathol.
31:597.
|
| 24.
|
Murphy, M. L.,
C. R. Engwerda,
P. M. A. Gorak, and P. M. Kaye.
1997.
B7-2 blockade enhances T cell responses to Leishmania donovani.
J. Imunnol.
159:4460-4466[Abstract].
|
| 25.
|
Nacy, C. A.,
B. J. Nelson,
M. S. Meltzer, and S. J. Green.
1991.
Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities.
Res. Immunol.
7:573-576.
|
| 26.
|
Olivry, T.,
P. F. Moore,
D. K. Naydan,
D. M. Danilenko, and V. K. Affolter.
1995.
Investigation of epidermotropism in canine mycosis fungoides: expression of intercellular adhesion molecule-1 (ICAM-1) and beta-2 integrins.
Arch. Dermatol. Res.
287:186-192[Medline].
|
| 27.
|
Pinelli, E.,
C. J. P. Boog,
V. P. M. G. Rutten,
B. Van Dijk,
W. Bernadina, and E. J. Ruitenberg.
1994.
A canine CD8+ cytotoxic T-cell line specific for Leishmania infantum infected macrophages.
Tissue Antigens
43:189-192[Medline].
|
| 28.
|
Pinelli, E.,
R. Killick-Kendrick,
J. Wagenaar,
W. Bernadina,
G. del Real, and E. J. Ruitenberg.
1994.
Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum.
Infect. Immun.
62:229-235[Abstract/Free Full Text].
|
| 29.
|
Pinelli, E.,
R. M. Gonzalo,
C. J. Boog,
V. P. Rutten,
D. Gebhard,
G. del Real, and J. Ruitenberg.
1995.
Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.
Eur. J. Immunol.
25:1594-1600[Medline].
|
| 30.
|
Prina, E.,
C. Jouanne,
S. de Souza Lao,
A. Szabo,
J.-G. Guillet, and J.-C. Antoine.
1993.
Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes.
J. Immunol.
151:2050-2061[Abstract].
|
| 31.
|
Probst, P.,
Y. A. W. Skeiky,
M. Steeves,
A. Gervassi,
K. H. Grabstein, and S. G. Reed.
1997.
A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor- production and expression of B7-1 in human monocyte-derived antigen presenting cells.
Eur. J. Immunol.
27:2634-2642[Medline].
|
| 32.
|
Reiner, N. E.
1987.
Parasite-accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of macrophage interleukin 1 response by Leishmania donovani.
J. Immunol.
138:1919-1925[Abstract].
|
| 33.
|
Reiner, N. E.,
N. G. Winnie, and W. R. McMaster.
1987.
Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products.
J. Immunol.
138:1926-1932[Abstract].
|
| 34.
|
Reiner, S. L.,
S. Zheng,
Z. E. Wang,
L. Stowring, and R. M. Locksley.
1994.
Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
J. Exp. Med.
179:447-456[Abstract/Free Full Text].
|
| 35.
|
Sacks, D. L.,
S. L. Lal,
S. N. Shrivastava,
J. Blackwell, and F. A. Neva.
1987.
An analysis of T cell responsiveness in Indian kala-azar.
J. Immunol.
138:908-913[Abstract].
|
| 36.
|
Saha, B.,
G. Das,
H. Vohra,
N. K. Ganguly, and G. C. Mishra.
1995.
Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity.
Eur. J. Immunol.
25:2492-2498[Medline].
|
| 37.
|
Snyder, D. S.,
C. Y. Lu, and E. R. Unanue.
1982.
Control of macrophage Ia expression in neonatal mice role of a splenic suppressor cell.
J. Immunol.
128:1458-1465[Abstract].
|
| 38.
|
Van Noesel, C.,
F. Miedema,
M. Brouwer,
M. A. de Rie,
L. A. Aarden, and R. A. W. van Lier.
1988.
Regulatory properties of LFA-1 and chains in human T cell activation.
Nature
333:850-852[Medline].
|
| 39.
|
Van Seventer, G. A.,
Y. Shimizu,
K. J. Horgan,
G. E. Ginther Luce,
D. Webb, and S. Shaw.
1991.
Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
Eur. J. Immunol.
21:1711-1718[Medline].
|
Infection and Immunity, January 1999, p. 237-243, Vol. 67, No. 1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Otranto, D., Paradies, P., de Caprariis, D., Stanneck, D., Testini, G., Grimm, F., Deplazes, P., Capelli, G.
(2009). Toward Diagnosing Leishmania infantum Infection in Asymptomatic Dogs in an Area Where Leishmaniasis Is Endemic. CVI
16: 337-343
[Abstract]
[Full Text]
-
SANCHEZ, M. A., DIAZ, N. L., ZERPA, O., NEGRON, E., CONVIT, J., TAPIA, F. J.
(2004). ORGAN-SPECIFIC IMMUNITY IN CANINE VISCERAL LEISHMANIASIS: ANALYSIS OF SYMPTOMATIC AND ASYMPTOMATIC DOGS NATURALLY INFECTED WITH LEISHMANIA CHAGASI. Am J Trop Med Hyg
70: 618-624
[Abstract]
[Full Text]
-
Brodskyn, C. I., DeKrey, G. K., Titus, R. G.
(2001). Influence of Costimulatory Molecules on Immune Response to Leishmania major by Human Cells In Vitro. Infect. Immun.
69: 665-672
[Abstract]
[Full Text]
-
Solano-Gallego, L., Morell, P., Arboix, M., Alberola, J., Ferrer, L.
(2001). Prevalence of Leishmania infantum Infection in Dogs Living in an Area of Canine Leishmaniasis Endemicity Using PCR on Several Tissues and Serology. J. Clin. Microbiol.
39: 560-563
[Abstract]
[Full Text]